About Abbott VascularAbbott Vascular, a division of Abbott, is one of the world’s leading vascular care businesses. Abbott Vascular is uniquely focused on transforming the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education lasixfurosemide.net . Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products that their safety, effectiveness their safety, effectiveness and ease of use in patients with vascular disease. For more information, visit Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.
Releasing About Abbott Vascular Drug Eluting Stent Program Abbott Vascular ‘s drug stent program consists of two flagship investigational drugs together. Both systems include advanced stent platform and controlled release of a drug from the – olimus class. XIENCE V utilizes the drug everolimus and the highly deliverable and proven MULTI – LINK VISION coronary stent platform. Everolimus has been shown to reduce tissue proliferation in the coronary vessels following stent implantation. The ZoMaxx drug-eluting stent system features zotarolimus a connection for use on for use on drug – eluting stents, and Abbott TriMaxx stainless steel and tantalum stent platform. Abbott Vascular is also developing bioabsorbable drug-eluting stents and drug-eluting stents, which use a combination of medications. Continue reading